CTN Bulletin logo
December 11, 2018

NIDA Seeks Comments on Epidemiology of Opioid Use

SHARE ISSUE ON 

Facebook

NIDA logo The National Institute on Drug Abuse (NIDA) issued a Request for Information (RFI) on Epidemiology of Opioid Use and Consequences- What is needed to understand and solve the crisis.

Deadline: Responses are due by December 27, 2018; send via email to: OpioidEpiRFI@nida.nih.gov

NIDA is requesting feedback from researchers, community stakeholders, and other interested public parties regarding the type of epidemiologic information that would be most useful to understand the opioid crisis and to inform prevention and treatment efforts. Opioids include prescription and illicit opioids, such as heroin, illicitly manufactured fentanyl, and related analogs.

Here is a sampling of some of the topics of particular interest:

  • Characterizations of subgroups that may be impacted by the opioid epidemic.
  • Detailed descriptions of risk factors, course, patterns of treatment-seeking, service availability and utilization, and how they differ among the various characterizations.
  • Development of integrated etiological models, and understanding of how do risk factors interact with each other.
  • Identifying the impact of the above factors and comorbidities on clinical trajectories and longer-term outcomes.
  • Utilizing epidemiologic data effectively to inform preventive interventions and vice versa.

Find more information about this request here . . .


email iconCTN Dissemination Library's Email Has Changed

The CTN Dissemination Library has a new email address!

Please contact us at ctnlib@uw.edu!

 

CTN Trial Progress

GraphRandomizations for Active Studies as of the December 10 trial Progress Report.

CTN-0067 - CHOICES Scale-Up. Enrolled 76

CTN-0068 - ADAPT-2 for Methamphetamine Use Disorder. Enrolled 339

CTN-0069 - OUD in the Emergency Department. Enrolled 394

CTN-0075 - Physician-Pharmacist Collaboration - OUD
Enrolled 76

CTN-0079 - ED-CONNECT Enrolled 18

Total randomizations in active trials: 903

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

Greater New York Node

AJPH logoIn a commentary published in the December 2018 issue of American Journal of Public Health, members of the Greater New York Node and colleagues describe strategies used in three states in the Northeast to address the opioid epidemic. The article is an outgrowth from a presentation at the symposium Harnessing Policy, Practice and Research to Address the Opioid Epidemic, held at New York University in September 2017.

"A key takeaway is that while innovative research continues and broad federal initiatives are launched, there are pragmatic, evidence-based actions that communities in crisis can take to make immediate differences. These initiatives focus on evidence-based policies and practices to (1) treat opioid use disorder (OUD), (2) reduce overdose deaths, and (3) limit opioid exposure."

Examples of strategies employed in Massachusetts, Vermont, and New York included expanding provider capacity to provide increased immediate access to OUD pharmacotherapies, collaborative care models that increase capacity for individualized care, expansion of naloxone distribution and improved opioid prescribing, and public awareness campaigns that reduce stigma by reframing addiction as a chronic medical condition and educating families on the risks and symptoms of OUD and promote treatment uptake.

· · · · · · · · · · · · · · · · · · · · · ·

Pacific Northwest Node

Northeast NodePosition Open: The University of Washington Alcohol & Drug Abuse Institute is seeking a new Director. This is a great opportunity to lead a highly successful and impactful research institute. ADAI is the home for the Pacific NW Node of the NIDA Clinical Trials Network and the Northwest Addiction Technology Transfer Center.

To apply: http://bit.ly/ADAI_director (click "Apply for this job" at the bottom of the page).

The ADAI Director reports to the Executive Director, Health Science Administration (HSA), for administrative oversight. Matters related to the scientific, health, information, and policy missions are managed and promoted by the Director with support from HSA. The University of Washington provides an extraordinary environment for discovery, teaching, and service. The University is recognized as one of the largest, most successful public universities in the world and a wide variety of partnerships are either existing or available to the Director to further the ADAI mission.

While ADAI is not an academic unit, opportunities exist for the Director to pursue joint academic appointment with an academic department depending on interest and alignment.

Read more about the responsibilities and requirements for this position here. . .



Northeast Node

Northeast NodeOn November 15th the Northeast NodeScience Series welcomed Kay Jankowski, PhD and Erin Knight, PhD from the Dartmouth Trauma Interventions Research Center at Dartmouth-Hitchcock Medical Center for a presentation entitled, "The Effects of Caregiver Substance Use Disorder on the Well-being of Children and Youth."

In their talk, Drs. Jankowski and Knight provided an overview of the scope of the problem, the effects of parental substance use on children and youth, and models for treating traumatized children that have high relevance and utility for children and youth coming from families with parental substance use.

Children exposed to parental substance use suffer from high rates of abuse, neglect, traumatic loss and posttraumatic sequelae. Approximately 1 in 8 children (8.7 million) aged 17 or younger live with at least one parent with a past year substance use disorder (2009 to 2014). Moreover, an estimated 40-80% of families involved with child protection services due to child abuse or neglect involve substance abuse in the home.

With high rates of substance use disorders, including opioid use disorders, and rising rates of death from drug overdose, services to meet the needs of the children and youth exposed to parental substance use are sorely lacking.

You can learn more about Drs. Jankowski and Knight’s work by viewing their full presentation on the Northeast Node's website.

We hope that you will join us for the next installment of our Science Series on January 24th, 2019 from 12:00-1:00 EST. Lisa Letourneau, MD, MPH, and Jeanne Ryer, MSc, EdD, will be presenting on using the ECHO Model to address the opioid epidemic in rural Northern New England.

For more information, or to join the Science Series mailing list, please email Bethany McLeman.

· · · · · · · · · · · · · · · · · · · · · ·

From the ATTC

ATTC logoThe ATTC Network has launched a new website: http://attcnetwork.org.

We're also celebrating our 25th anniversary this year! In the year ahead, the ATTC/NIATx Service Improvement Blog will feature posts celebrating innovation and impact. Dr. Michael Flaherty launched the series with his post: Building a Science of Recovery: The Pinnacle of ATTC Achievement?


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Updates to the CTN Investigator Toolbox from the Addiction Technology Transfer Center (ATTC)

CTN logoThe CTN Investigator Toolbox is an online resource for CTN investigators. It contains detailed information and guidance documents to help investigators navigate the CTN study process from protocol concept and development through protocol implementation and close-out.

The Clinical Coordinating Center (CCC) recently updated the Investigator Agreement (IA) to version 4.0, removing the requirement for sites to submit the original "wet" signature document to the CCC. Sites are instructed to maintain the original document in their local regulatory binder and to submit an electronic version to the CCC (e.g., via the regulatory tracking system (Veeva Vault)).

Make sure to check out Version 4.0 of the IA and its associated Guidance Document in the "Pre-Implementation / Regulatory" section of the Toolbox.

For help logging into the Toolbox, questions, or comments, or if you have suggestions for items you’d like to see added to the Toolbox, please contact Dee Blumberg at dblumberg@emmes.com or Julia Collins at jcollins@emmes.com.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

New in the CTN Dissemination Library

journal coversTobacco Use During Cannabis Cessation: Use Patterns and Impact on Abstinence in a National Drug Abuse Treatment Clinical Trials Network Study. McClure EA, et al. Drug and Alcohol Dependence 2018;192:59-66.

Cardiorespiratory Fitness and Body Composition of Stimulant Users: A Baseline Analysis of the STRIDE Cohort. Stoutenberg M, et al. Journal of Substance Abuse Treatment 2017;78:74-79.

Structural Factors Affecting Asians and Pacific Islanders in Community-based Substance Use Treatment: Treatment Providers' Perspectives. Chang JS, et al. Journal of Ethnicity in Substance Abuse 2017;17(4):479-494.

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification. McCollister KE, et al. American Journal of Managed Care 2018;24(11):522-527.

Prevalence and Patterns of Opioid Misuse and Opioid Use Disorder Among Primary Care Patients Who Use Tobacco. John WS, et al. Drug and Alcohol Dependence 2019;194:468-475.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Upcoming Events

CTN Webinar: Regulatory Matters in Clinical Research (December 12, 2pm ET) Register here!

Also of Interest

Call for Applicants for LEAD Program: New Deadline.

Submit your application for the USCF Learning for Early Careers in Addiction and Diversity (LEAD) Program by January 31, 2019! Find out more here. . .

 

NIDA Director Receives Highest Honor by Georgetown University Medical Center

Nora VolkowDr. Nora Volkow, director of the National Institute on Drug Abuse, was recently presented with Georgetown University Medical Center (GUMC)'s highest honor, the Cura Personalis Award, which is bestowed to a health professional who has made outstanding contributions to human health guided by compassion and service.

Dr. Volkow received the Cura Personalis medal during the 11th Annual GUMC Convocation on Tuesday, November 13th at GUMC's campus in Washington, DC. For more information, read: Georgetown University Medical Center’s news release.

     

Published by the CTN Dissemination Library of the Pacific Northwest Node
Alcohol & Drug Abuse Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol & Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe

Copyright (C) 2016 Alcohol and Drug Abuse Institute. All rights reserved.